Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) EPS (Basic) (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed EPS (Basic) for 13 consecutive years, with -$1.56 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 80.52% to -$1.56 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.91, a 58.14% increase, with the full-year FY2025 number at -$4.91, up 41.76% from a year prior.
  • EPS (Basic) was -$1.56 for Q4 2025 at Ekso Bionics Holdings, down from -$0.34 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.1 in Q2 2021 to a low of -$8.01 in Q4 2024.
  • A 5-year average of -$0.99 and a median of -$0.32 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): skyrocketed 94.82% in 2021, then crashed 3540.91% in 2024.
  • Ekso Bionics Holdings' EPS (Basic) stood at -$0.23 in 2021, then decreased by 4.35% to -$0.24 in 2022, then increased by 8.33% to -$0.22 in 2023, then plummeted by 3540.91% to -$8.01 in 2024, then surged by 80.52% to -$1.56 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's EPS (Basic) are -$1.56 (Q4 2025), -$0.34 (Q3 2025), and -$2.89 (Q2 2025).